Investment Summary

Illumina Invests In 4SR Biosciences

On March 16, 2022, Illumina invested in life science company 4SR Biosciences

Investment Highlights
  • This is Illumina’s 12th transaction in the Life Science sector.
  • This is Illumina’s 18th transaction in the United States.
  • This is Illumina’s 1st transaction in Illinois.

Investment Summary
Date 2022-03-16
Target 4SR Biosciences
Sector Life Science
Investor(s) Illumina
Deal Type Stake Purchase

Target

4SR Biosciences

Chicago, Illinois, United States
4SR Biosciences is a diagnostics and therapeutics company from the University of Chicago, that is using proprietary technology to explore new tRNA-based modalities for disease biomarkers and cancer therapeutics. 4SR Biosciences is based in Chicago, Illinois.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Illumina

San Diego, California, United States
Category Company
Founded 1998
Sector Life Science
Employees10,590
Revenue 4.5B USD (2023)
DESCRIPTION
Entrance to Illumina's corporate headquarters in San Diego, California.
Entrance to Illumina's corporate headquarters in San Diego, California.

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. The Company's customers include genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. Illumina was formed in 1998 and is based in San Diego, California.

DEAL STATS #
Overall 22 of 29
Sector (Life Science) 12 of 18
Type (Stake Purchase) 7 of 13
State (Illinois) 1 of 1
Country (United States) 18 of 20
Year (2022) 7 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-16 Rethink Bio

Pune, India

Rethink Bio is a synthetic biology company focused on harnessing the potential of microalgae to develop sustainable food solutions to benefit the planet and people. Rethink Bio was founded in 2020 and is based in Pune, India.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-14 Dama Health

London, United Kingdom

Dama Health is a women's health company that offers precision screening to identify the most suitable contraception type and formulation, empowering women, people assigned to females at birth, and clinicians to make personalized reproductive health decisions. Dama Health is based in London, United Kingdom.

Buy -
Mergr

Product

Company

Legal